Dementia in Latin America: Paving the way toward a regional action plan
- PMID: 33634602
- PMCID: PMC7984223
- DOI: 10.1002/alz.12202
Dementia in Latin America: Paving the way toward a regional action plan
Abstract
Across Latin American and Caribbean countries (LACs), the fight against dementia faces pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic disparities. These can be addressed more effectively in a collaborative setting that fosters open exchange of knowledge. In this work, the Latin American and Caribbean Consortium on Dementia (LAC-CD) proposes an agenda for integration to deliver a Knowledge to Action Framework (KtAF). First, we summarize evidence-based strategies (epidemiology, genetics, biomarkers, clinical trials, nonpharmacological interventions, networking, and translational research) and align them to current global strategies to translate regional knowledge into transformative actions. Then we characterize key sources of complexity (genetic isolates, admixture in populations, environmental factors, and barriers to effective interventions), map them to the above challenges, and provide the basic mosaics of knowledge toward a KtAF. Finally, we describe strategies supporting the knowledge creation stage that underpins the translational impact of KtAF.
Keywords: Latin America; biomarkers; clinical trials; dementia; epidemiology; evidence-based recommendations; genetics; knowledge to action framework; networking and translational research; nonpharmacological interventions.
© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.
Conflict of interest statement
The Expert Meeting was supported by Alzheimer's Society UK grants awarded to MP in collaboration with AI (AS‐R42303, AS‐SF‐14‐008). AS is supported by CONICYT / FONDAP /15150012; Conicyt/ Fondecyt Regular/ 1140423 and Basal Funds for Centers of Excellence, Project FB 0003 from the Associative Research Program of CONICYT. FL is supported by a grant API COLOMBIA funded by GENENTECH and Banner Institute. FK is supported by a National Health and Medical Research Council of Australia (NHMRC)‐Australian Research Council Dementia Research Development Fellowship (APP1097026). OP is supported by an NHMRC Senior Research Fellowship (APP1103258). FFDO is supported by FAPESP ‐ The State of São Paulo Research Foundation (grant #2015/10109‐5). The support from Alzheimer´s Scotland Dementia Research and the Centre for Cognitive Ageing and Cognitive Epidemiology part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1) both from the University of Edinburgh is also acknowledged. FS is supported by Geroscience Center for Brain Health and Metabolism (FONDAP‐15150012) and Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT, No. 1150766). RAV is supported by CONICYT AFB 170008 and by Faculty of Sciences, University of Chile, PAIFAC grant. PC is supported by CNPq, Brazil (bolsa de produtividade em pesquisa). PL is supported by FONDAP Program Grant 15150012 & by Conicyt/Fondecyt Regular/ 1160940. STF is supported by National Institute for Translational Neuroscience (Brazil, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil). BCB is supported by Alzheimer's Association and Global Brain Health Institute (GBHI_ALZ‐18‐542347). LTG is supported by NIH K24AG053435. MLFC is supported by CNPq (bolsa de produtividade em pesquisa). RDR is supported by FAPESP (2016/24326‐0) and the Alzheimer´s Association (AARF‐18‐566005). LD is partially supported by Neuromedicenter. RF is supported by Alzheimer's Society (grant # 284). LCS is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil). MSY is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and São Paulo Research Foundation (FAPESP/BRAZIL). MACB is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and Minas Gerais Research Foundation (FAPEMIG/BRAZIL). IA receives National public grant level 2 from the National Council for Scientific and Technological Development (Ministry of Science, Technology, Innovation and Communications, Brazil). HMS is a full‐time employee of the Alzheimer's Association. AI is partially supported by grants from CONICET, FONCyT‐PICT 2017‐1818, FONCyT‐PICT 2017‐1820, FONDAP 15150012, the Interamerican Development Bank (IDB), Alzheimer's Association GBHI ALZ UK‐20‐639295, and the MULTI‐PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat, supported by National Institutes of Health, National Institute on Aging (R01 AG057234), Alzheimer's Association (SG‐20‐725707), Tau Consortium, and Global Brain Health Institute)]. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these Institutions. The other authors declare no conflict of interests.
Figures



Similar articles
-
Biomarkers for dementia in Latin American countries: Gaps and opportunities.Alzheimers Dement. 2023 Feb;19(2):721-735. doi: 10.1002/alz.12757. Epub 2022 Sep 13. Alzheimers Dement. 2023. PMID: 36098676 Free PMC article.
-
The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science.J Alzheimers Dis. 2021;82(s1):S379-S394. doi: 10.3233/JAD-201384. J Alzheimers Dis. 2021. PMID: 33492297 Free PMC article.
-
The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science.Front Neurol. 2021 Mar 11;12:631722. doi: 10.3389/fneur.2021.631722. eCollection 2021. Front Neurol. 2021. PMID: 33776890 Free PMC article. Review.
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
-
Dementia in Latin America: Assessing the present and envisioning the future.Neurology. 2018 Jan 30;90(5):222-231. doi: 10.1212/WNL.0000000000004897. Epub 2018 Jan 5. Neurology. 2018. PMID: 29305437 Free PMC article. Review.
Cited by
-
Biomarkers for dementia in Latin American countries: Gaps and opportunities.Alzheimers Dement. 2023 Feb;19(2):721-735. doi: 10.1002/alz.12757. Epub 2022 Sep 13. Alzheimers Dement. 2023. PMID: 36098676 Free PMC article.
-
Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.Front Neurol. 2022 Sep 1;13:962192. doi: 10.3389/fneur.2022.962192. eCollection 2022. Front Neurol. 2022. PMID: 36119675 Free PMC article.
-
Mental health impact of the COVID-19 pandemic on patients with neurodegenerative diseases and perceived family caregiver burden in Lima, Peru.Brain Behav. 2024 Jan;14(1):e3361. doi: 10.1002/brb3.3361. Brain Behav. 2024. PMID: 38236201 Free PMC article.
-
The Brain Health Diplomat's Toolkit: supporting brain health diplomacy leaders in Latin America and the Caribbean.Lancet Reg Health Am. 2023 Nov 17;28:100627. doi: 10.1016/j.lana.2023.100627. eCollection 2023 Dec. Lancet Reg Health Am. 2023. PMID: 38046464 Free PMC article. Review.
-
Structural Brain Differences in the Alzheimer's Disease Continuum: Insights Into the Heterogeneity From a Large Multisite Neuroimaging Consortium.Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Jul 30:S2451-9022(24)00207-6. doi: 10.1016/j.bpsc.2024.07.019. Online ahead of print. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 39084525
References
-
- Addressing global dementia. Lancet. 2014;383(9936):2185. - PubMed
-
- Alladi S, Hachinski V. World dementia: one approach does not fit all. Neurology. 2018;91(6):264‐270. - PubMed
-
- Dartigues JF. Alzheimer's disease: a global challenge for the 21st century. Lancet Neurol. 2009;8(12):1082‐1083. - PubMed
-
- Shah H, Albanese E, Duggan C, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016;15(12):1285‐1294. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous